A phase 1b/2a, multi-center, open-label study to evaluate the safety and efficacy of combination treatment with MEDI0457 (INO-3112) and durvalumab (MEDI4736) in patients with recurrent/metastatic human papilloma virus–associated head and neck squamous cell cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS6093-TPS6093 ◽  
Author(s):  
Charu Aggarwal ◽  
Balazs Halmos ◽  
Mercedes Porosnicu ◽  
Nabil F. Saba ◽  
Ammar Sukari ◽  
...  
2011 ◽  
Vol 47 ◽  
pp. S550-S551
Author(s):  
I. Asvadi Kermani ◽  
S. Seifi ◽  
R. Dolatkhah ◽  
A. Asvadi Kermani ◽  
E. Sakhinia ◽  
...  

2020 ◽  
Vol 25 (9) ◽  
Author(s):  
Aleksei Viktorovich Novik ◽  
Anna Borisovna Danilova ◽  
Maksim Ivanovich Sluzhev ◽  
Tatiana Leonidovna Nehaeva ◽  
Sergei Sergeevich Larin ◽  
...  

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e16011-e16011
Author(s):  
I. A. Kermani ◽  
S. Seifi ◽  
A. Asvadi Kermani ◽  
R. Dolatkhah ◽  
E. Sakhinia ◽  
...  

Author(s):  
Sofia Ish‐Shalom ◽  
Yoseph Caraco ◽  
Nariman Saba Khazen ◽  
Michal Gershinsky ◽  
Auryan Szalat ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document